LONZA GROUP AG-REG (1LONN.MI) Stock Price & Overview
BIT:1LONN • CH0013841017
Current stock price
The current stock price of 1LONN.MI is 550 EUR. Today 1LONN.MI is down by -0.9%.
1LONN.MI Key Statistics
- Market Cap
- 38.627B
- P/E
- 33.29
- Fwd P/E
- 27.27
- EPS (TTM)
- 16.52
- Dividend Yield
- 1.06%
1LONN.MI Stock Performance
1LONN.MI Stock Chart
1LONN.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1LONN.MI.
1LONN.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to 1LONN.MI. 1LONN.MI has only an average score on both its financial health and profitability.
1LONN.MI Earnings
On January 28, 2026 1LONN.MI reported an EPS of 7.52 and a revenue of 4.05B. The company missed EPS expectations (-22.18% surprise) and beat revenue expectations (0.35% surprise).
1LONN.MI Forecast & Estimates
31 analysts have analysed 1LONN.MI and the average price target is 751.85 EUR. This implies a price increase of 36.7% is expected in the next year compared to the current price of 550.
For the next year, analysts expect an EPS growth of 22.05% and a revenue growth -2.34% for 1LONN.MI
1LONN.MI Groups
Sector & Classification
1LONN.MI Financial Highlights
Over the last trailing twelve months 1LONN.MI reported a non-GAAP Earnings per Share(EPS) of 16.52. The EPS increased by 0.13% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.33% | ||
| ROA | 3.9% | ||
| ROE | 8.5% | ||
| Debt/Equity | 0.49 |
1LONN.MI Ownership
1LONN.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 56S1 | SARTORIUS STEDIM BIOTECH | 32.3 | 16.541B | ||
| DIM | SARTORIUS STEDIM BIOTECH | 32 | 16.459B | ||
| SRT3 | SARTORIUS AG-VORZUG | 36.15 | 15.905B | ||
| SRT | SARTORIUS AG | 28.73 | 12.52B | ||
| QIA | QIAGEN N.V. | 15.47 | 7.276B | ||
| 1SXP | SCHOTT PHARMA AG& CO KGAA | 12.45 | 2.063B | ||
| 1EVT | EVOTEC SE | N/A | 1.598B | ||
| EVT | EVOTEC SE | N/A | 800.994M | ||
| GXI | GERRESHEIMER AG | 6.82 | 641.062M | ||
| FF | FINE FOODS & PHARMACEUTICALS | 11.95 | 183.539M | ||
| ALECR | EUROFINS CEREP-REGR | N/A | 154M | ||
| MLC | MALIN CORP PLC | N/A |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1LONN.MI
Company Profile
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. The company is headquartered in Basel, Basel-Stadt and currently employs 19,771 full-time employees. The company went IPO on 2002-04-03. The firm's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The firm divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.
Company Info
IPO: 2002-04-03
LONZA GROUP AG-REG
Muenchensteinerstrasse 38
Basel BASEL-STADT CH
Employees: 19299
Phone: 41613168111
LONZA GROUP AG-REG / 1LONN.MI FAQ
What does LONZA GROUP AG-REG do?
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. The company is headquartered in Basel, Basel-Stadt and currently employs 19,771 full-time employees. The company went IPO on 2002-04-03. The firm's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The firm divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.
What is the stock price of LONZA GROUP AG-REG today?
The current stock price of 1LONN.MI is 550 EUR. The price decreased by -0.9% in the last trading session.
Does 1LONN stock pay dividends?
LONZA GROUP AG-REG (1LONN.MI) has a dividend yield of 1.06%. The yearly dividend amount is currently 4.39.
What is the ChartMill technical and fundamental rating of 1LONN stock?
1LONN.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
On which exchange is 1LONN.MI stock listed?
1LONN.MI stock is listed on the Euronext Milan exchange.
How is the valuation of LONZA GROUP AG-REG (1LONN.MI) based on its PE ratio?
The PE ratio for LONZA GROUP AG-REG (1LONN.MI) is 33.29. This is based on the reported non-GAAP earnings per share of 16.52 and the current share price of 550 EUR.
Is LONZA GROUP AG-REG (1LONN.MI) expected to grow?
The Revenue of LONZA GROUP AG-REG (1LONN.MI) is expected to decline by -2.34% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.